157 related articles for article (PubMed ID: 38534926)
21. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.
Clay J; Kulasekararaj AG; Potter V; Grimaldi F; McLornan D; Raj K; de Lavallade H; Kenyon M; Pagliuca A; Mufti GJ; Marsh JC
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1711-6. PubMed ID: 25016195
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
[TBL] [Abstract][Full Text] [Related]
24. Successful engraftment of haploidentical bone marrow with post-transplantation cyclophosphamide in patients with aplastic anemia.
Dang BN; De Oliveira S; Gray A; Bowles L; Moore TB
Pediatr Transplant; 2020 Mar; 24(2):e13652. PubMed ID: 31944531
[TBL] [Abstract][Full Text] [Related]
25. Alternative Transplantation With Post-Transplantation Cyclophosphamide in Aplastic Anemia: A Retrospective Report From the BMF-WG of Hunan Province, China.
Gong S; Chen C; Chen K; Yang R; Wang L; Yang K; Hu J; Nie L; Su T; Xu Y; He X; Yang L; Xiao H; Fu B
Transplant Cell Ther; 2023 Jan; 29(1):48.e1-48.e7. PubMed ID: 36272527
[TBL] [Abstract][Full Text] [Related]
26. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
[TBL] [Abstract][Full Text] [Related]
27. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
Childs RW; Tian X; Vo P; Purev E; Kotecha RR; Carlsten M; Clara J; Flegel WA; Adams SD; Khuu HM; Stroncek DF; Cook L; Worthy T; Geller NL; Wells B; Wilder J; Reger R; Aue G
Br J Haematol; 2021 Jun; 193(5):951-960. PubMed ID: 33993466
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of haploidentical bone marrow transplantation in patients with severe aplastic anemia-II that progressed from non-severe acquired aplastic anemia.
Liu H; Zheng X; Zhang C; Xie J; Gao B; Shao J; Yang Y; Wang H; Yan J
Front Med; 2021 Oct; 15(5):718-727. PubMed ID: 34170455
[TBL] [Abstract][Full Text] [Related]
29. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
30. Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34
Cao LQ; Xu LP; Zhang XH; Wang Y; Liu YR; Liu KY; Huang XJ; Chang YJ
Chin Med J (Engl); 2018 Sep; 131(18):2185-2192. PubMed ID: 30203793
[TBL] [Abstract][Full Text] [Related]
31. Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings.
Xu ZL; Huang XJ
Expert Rev Hematol; 2021 May; 14(5):449-455. PubMed ID: 33945370
[No Abstract] [Full Text] [Related]
32. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
[TBL] [Abstract][Full Text] [Related]
33. Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
Ma X; Zuo Y; Xu Z; Zhang Y; Cheng Y; Han T; Suo P; Sun Y; Tang F; Wang F; Yan C; Chen Y; Wang Y; Zhang X; Liu K; Huang X; Xu L
Ann Hematol; 2022 Aug; 101(8):1815-1823. PubMed ID: 35739427
[TBL] [Abstract][Full Text] [Related]
34. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
[TBL] [Abstract][Full Text] [Related]
35. Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia: A Retrospective Controlled Study.
Sheng XF; Li H; Hong LL; Zhuang H
Turk J Haematol; 2022 Jun; 39(2):117-129. PubMed ID: 35448935
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
[No Abstract] [Full Text] [Related]
37. Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Alotaibi H; Aljurf M; de Latour R; Alfayez M; Bacigalupo A; Fakih RE; Schrezenmeier H; Ahmed SO; Gluckman E; Iqbal S; Höchsmann B; Halkes C; de la Fuente J; Alshehry N; Cesaro S; Passweg J; Dufour C; Risitano AM; DiPersio J; Motabi I
Transplant Cell Ther; 2022 Feb; 28(2):105.e1-105.e7. PubMed ID: 34649020
[TBL] [Abstract][Full Text] [Related]
38. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation.
Wu L; Zhou M; Li Y; Chen X; Mo W; Wang C; Xu S; Zhou W; Deng T; Zhou R; Pan S; Wang S; Zhang Y
Transplant Cell Ther; 2023 Jul; 29(7):463.e1-463.e7. PubMed ID: 37098408
[TBL] [Abstract][Full Text] [Related]
39. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia.
Li XH; Gao CJ; Da WM; Cao YB; Wang ZH; Xu LX; Wu YM; Liu B; Liu ZY; Yan B; Li SW; Yang XL; Wu XX; Han ZC
PLoS One; 2014; 9(3):e89666. PubMed ID: 24594618
[TBL] [Abstract][Full Text] [Related]
40. Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China.
Zeng Y; Wang S; Wang J; Liu L; Su Y; Lu Z; Zhang X; Zhang Y; Zhong JF; Peng L; Liu Q; Lu Y; Gao L; Zhang X
Sci Rep; 2018 Feb; 8(1):2479. PubMed ID: 29410500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
